Synergistic effect of lupenone and caryophyllene oxide against Trypanosoma cruzi

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Polanco Hernández, Glendy ^a   Escalante Erosa, Fabiola ^a   García Sosa, Karlina ^a   Rosado, María E ^b   Guzmán Marín, Eugenia ^b   Acosta Viana, Karla Y ^b   Giménez Turba, Alberto ^c   Salamanca, Efraín ^c   Peña Rodríguez, Luis M ^a  

^a CENTRO DE INVESTIGACIÓN CIENTÍFICA DE YUCATÁN   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^c UNIVERSIDAD MAYOR DE SAN ANDRÉS   (Bolivia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; CARYOPHYLLENE OXIDE; LUPENONE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG POTENTIATION; EPIMASTIGOTE; HEART; HISTOPATHOLOGY; IC 50; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SURVIVAL RATE; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

EID: 84878691440     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/435398     Document Type: Article

References (31)

1. Romero R., Microbiología y Parasitología Humana 1999 Mexico City, Mexico Médica Panamericana
2. World Health Organization (WHO),. Descriptive note No.340, 2010, http://www.who.int/mediacentre/factsheets/fs340/es/
3. Castro J. A., De Mecca M. M., Bartel L. C., Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Human & Experimental Toxicology 2006 25 8 471 479 2-s2.0-33748669644 10.1191/0960327106het653oa (Pubitemid 44384589)
4. Issa V. S., Bocchi E. A., Antitrypanosomal agents: Treatment or threat? The Lancet 2010 376 9743 768 2-s2.0-77956385531 10.1016/S0140-6736(10)61372-4
5. Rodríguez M. A., Nuevas perspectivas en el manejo terapeútico de la enfermedad de Chagas. Revista Peruana de Medicina Experimental y Salud Pública 2005 22 123 131
6. World Health Organization (WHO), Special Programme for Research and Training in Tropical Disease (TDR), Natural products for parasitic diseases. TDR News 2000 62 4
7. Herrmann F., Wink M., Synergistic interactions of saponins and monoterpenes in Hela cells, Cos 7 cells and in erythrocytes. Phytomedicine 2011 18 1191 1196
8. Wagner H., Synergy research: Approaching a new generation of phytopharmaceuticals. Fitoterapia 2011 82 1 34 37 2-s2.0-79151482960 10.1016/j.fitote.2010.11.016
9. World Health Organization (WHO), Reporte mundial de malaria. 2011, http://www.who.int/malaria/world-malaria-report-2011/es/index.html
10. Polanco-Hernández G., Escalante-Erosa F., García-Sosa K., Acosta-Viana K., Chan-Bacab M. J., Sagua-Franco H., González J., Osorio-Rodríguez L., Moo-Puc R. E., Peña-Rodríguez L. M., In vitro and in vivo trypanocidal activity of native plants from the Yucatan Peninsula. Parasitology Research 2012 110 31 35 2-s2.0-79955868161 10.1007/s00436-011-2447-8
11. Polanco-Hernández G., Escalante-Erosa F., García-Sosa K., Chan-Bacab M., Sagua H., González J., Osorio L., Peña- Rodríguez L. M., Metabolites from the leaf extract of Serjania yucatanensis with trypanocidal activity against Trypanosoma cruzi. Parasitology Research 2012 111 451 455
12. Barrera-Pérez M., Rodríguez-Félix M. E., Guzmán-Marín E., Zavala J., Dumonteil E., Biological behaviour of three strains of Trypanosoma cruzi from Yucatan, Mexico. Revista Biomédica 2001 12 224 230
13. Camargo E. P., Growth and differentiation in Trypanosoma cruzi. I.Origin of metacyclic trypomastigotes in liquid medium. Revista do Instituto de Medicina Tropical de São Paulo 1964 12 93 100 2-s2.0-78651145402
14. Rojas J., Satalaya J. R., Grandez M., Vilchez L., Rengifo E., Salamanca E., Flores N., Giménez A., Ávila J. A., Ruiz G., Actividad leishmanicida de plantas medicinales de la amazonía peruana. Revista Boliviana de Química 2009 26 1 8
15. Yardley V., Croft S. L., In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections. The American Journal of Tropical Medicine and Hygiene 1999 61 2 193 197 2-s2.0-0032801314 (Pubitemid 29380248)
16. Cencig S., Coltel N., Truyens C., Carlier Y., Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with Ambisome. PLoS Neglected Tropical Diseases 2011 5 6 2-s2.0-79959850705 10.1371/journal.pntd. 0001216 e1216
17. Berenbaum M. C., What is synergy? Pharmacological Reviews 1989 41 2 93 141 2-s2.0-0024847290 (Pubitemid 20019599)
18. Jiménez-Coello M., Guzmán-Marín E., Pérez-Gutiérrez S., Polanco-Hernández G. M., Acosta-Viana K. Y., Antitrypanosomal activity of Senna villosa in infected Balb/C mice with Trypanosoma cruzi during the sub acute phase of infection. African Journal of Traditional Complementary and Alternative Medicines 2011 8 164 169
19. Rodrigues Esperandim V., da Silva Ferreira D., Saraiva J., E Silva M. L. A., Costa E. S., Pereira A. C., Bastos J. K., De Albuquerque S., Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones. Parasitology Research 2010 107 3 525 530 2-s2.0-77955467324 10.1007/s00436-010-1885-z
20. Rosas L. V., Cordeiro M. S. C., Campos F. R., Nascimento S. K. R., Januário A. H., França S. C., Nomizo A., Toldo M. P. A., Albuquerque S., Pereira P. S., In vitro evaluation of the cytotoxic and trypanocidal activities of Ampelozizyphus amazonicus (Rhamnaceae). Brazilian Journal of Medical and Biological Research 2007 40 5 663 670 2-s2.0-34248148565 (Pubitemid 46711711)
21. Setzer W., Stokes S., Bansal A., Haber W., Caffrey C., Hansell E., McKerrow E. J., Chemical composition and cruzain inhibitory activity of Croton draco bark essential oil from Monteverde, Costa Rica. Natural Products Communications 2007 2 685 689
22. Hata K., Hori K., Takahashi S., Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line. Journal of Natural Products 2002 65 5 645 648 2-s2.0-0036098929 10.1021/np0104673 (Pubitemid 34547402)
23. Na M., Kim B. Y., Osada H., Ahn J. S., Inhibition of protein tyrosine phosphatase 1B by lupeol and lupenone isolated from Sorbus commixta. Journal of Enzyme Inhibition and Medicinal Chemistry 2009 24 4 1056 1059 2-s2.0-73449131256
24. Yang D., Michel L., Chaumont J. P., Millet-Clerc J., Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis. Mycopathologia 1999 148 2 79 82 2-s2.0-0033285942 10.1023/A:1007178924408 (Pubitemid 32044914)
25. Lin W. Y., Kuo Y. H., Chang Y. L., Teng C. M., Wang E. C., Ishikawa T., Chen I. S., Anti-platelet aggregation and chemical constituents from the rhizome of Gynura japonica. Planta Medica 2003 69 8 757 764 2-s2.0-0141482080 10.1055/s-2003-42796 (Pubitemid 37215027)
26. Escobar P., Leal S. M., Herrera L. V., Martínez J. R., Stashenko E., Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components. Memorias do Instituto Oswaldo Cruz 2010 105 2 184 190 2-s2.0-77951900223
27. Díaz-Limay E., Escalante H., Jara C. A., Niveles de parasitemia y alteraciones histopatológicas en Mus Musculus BALB/C infectado con Trypanosoma cruzi obtenido de Panstrongylus chinai del Valle Chamán, La Libertad, Perú Parasitologia Latinoamericana 2004 59 3-4 153 158 2-s2.0-33746109195
28. Veiga-Santos P., Barrias E., Santos J. F. C., Barros-Moreira T. L., Ulisses da Carvalho T. M., Urbina J., de Souza W., Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi. International Journal of Antimicrobial Agents 2012 40 61 71
29. López-Muñoz R., Faúndez M., Klein S., Escanilla S., Torres G., Lee-Liu D., Ferreira J., Kemmerling U., Orellana M., Morello A., Ferreira A., Maya J. D., Trypanosoma cruzi: in vitro effect of aspirin with nifurtimox and benznidazole. Experimental Parasitology 2010 124 2 167 171 2-s2.0-73649109547 10.1016/j.exppara.2009.09.005
30. Pelizzaro-Rocha K. J., Tiuman T. S., Izumi E., Ueda-Nakamura T., Filho B. P. D., Nakamura C. V., Synergistic effects of parthenolide and benznidazole on Trypanosoma cruzi. Phytomedicine 2010 18 1 36 39 2-s2.0-78649782166 10.1016/j.phymed.2010.09.005
31. Araújo M. S. S., Martins-Filho O. A., Pereira M. E. S., Brener Z., A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. Journal of Antimicrobial Chemotherapy 2000 45 6 819 824 2-s2.0-0343527887 (Pubitemid 30348953)